Cargando…
Efficacy and Safety of Direct Oral Anticoagulants in Venous Thromboembolism Compared to Traditional Anticoagulants in Morbidly Obese Patients: A Systematic Review and Meta-Analysis
Background Randomized clinical trials comparing the efficacy and safety of direct oral anticoagulants (DOAC) with vitamin K antagonist (VKA) or low molecular weight heparin (LMWH) for the treatment of venous thromboembolism (VTE) generally exclude patients who are morbidly obese (body mass index ≥ 4...
Autores principales: | Katel, Anjan, Aryal, Madan, Neupane, Arun, Gosain, Rohit, Pathak, Ranjan, Bhandari, Yashoda, Kouides, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135070/ https://www.ncbi.nlm.nih.gov/pubmed/34026385 http://dx.doi.org/10.7759/cureus.14572 |
Ejemplares similares
-
Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
por: Aryal, Madan Raj, et al.
Publicado: (2020) -
Factor XIII Deficiency Associated With Noonan Syndrome
por: Kharel, Zeni, et al.
Publicado: (2021) -
New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010) -
New anticoagulants for the treatment of venous thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2016) -
Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)